VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2018 | New drugs for CML: are more to come?

Speaking from the American Society of Oncology (ASCO) 2018, held in Chicago, IL, Michael Mauro, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, talks about the future uses of asciminib and other novel drugs currently being developed for chronic myeloid leukemia (CML), before mentioning his hopes for the future of this disease with regards to patient remission.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter